课题基金 / 基金详情

Institutional Career Development Core

Institutional Career Development Core
机构职业发展核心
批准号:
10674063
负责人:
JEANINE M. GENKINGER
金额:
$139.76万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-07-01 至 2026-05-31

项目摘要

项目成果

JEANINE M. GENKINGER的其他基金

相似基金

相关文献

中文摘要
翻译
我们建议的KL 2指导职业发展奖励计划的目标是保持卓越 和导师计划,传授在跨学科团队科学,精准医学(PM),大数据和实施科学时代进行临床和转化科学所必需的技能。在哥伦比亚大学欧文医学中心(CUIMC),KL 2计划跨学校,部门和部门运作,作为唯一的机构- 在临床和转化研究中广泛的疾病不可知的职业发展计划。欧文号 研究所的临床医生和非临床医生科学家的翻译劳动力发展(TWD)集中在 转型(多学科研究的培训和培养学者),负责监督 机构职业发展核心(KL 2辅导职业发展奖励计划)。目标是 招募进行前沿和临床相关研究的个人,无论疾病如何 专心点招募将侧重于来自不同背景的研究者,包括研究或健康专业人员 医学、外科、护理、牙科、公共卫生、精神病学、艺术和科学博士,以及 工程. KL 2计划将促进职业发展,翻译能力和协作, 来自不同学科的初级教师的创业技能,他们最近完成了研究或健康 专业博士培训。KL 2毕业生将获得优秀和广泛的职业指导,并获得 在先进的临床和转化研究方法和综合实验方法的专业知识。 这种指导和培训将使KL 2学者能够更有效地竞争外部资金,提高 有效参与跨学科团队,为疾病预防和治疗做出贡献 通过临床和转化研究。我们的KL 2毕业生也将能够通过以下方式支付这些技能: 培训和指导下一代科学家。因此,具体目标是:目标1。继续 我们成功和创新的KL 2职业发展计划,并开发新的计划,以提高 我们的KL 2学者的能力,从事和领导跨学科团队科学和翻译新发现, 使我们的患者和社区受益。目标2.为了证明KL 2计划的有效性, 持续的全面和系统的评价和质量改进使用的关键指标,包括 共同努力,优化我们的教育和劳动力发展计划的影响。目标3:到 加快传播我们的培训方法,我们的合作伙伴在哥伦比亚大学(CU),区域 临床和转化科学奖(CTSA)项目中心和网络的三州联盟(TriCon), 临床和翻译,同时加强和创新我们成功的初级教师培训领域。
英文摘要
The goal for our proposed KL2 Mentored Career Development Award Program is to maintain excellence and mentorship program that imparts the skills essential to conduct clinical and translational science in the era of interdisciplinary team science, precision medicine (PM), big data, and implementation science. At Columbia University Irving Medical Center (CUIMC), the KL2 program operates across schools, departments, and divisions as the only institution- wide disease-agnostic career development program in clinical and translational research. The Irving Institute's translational workforce development (TWD) of clinician and non-clinician scientists is centered in TRANSFORM (TRaining And Nurturing Scholars For Research that is Multidisciplinary), which oversees the Institutional Career Development Core (KL2 Mentored Career Development Award Program). The goal is to recruit individuals who conduct cutting edge and clinically relevant research regardless of the disease focus. Recruitment will focus on investigators from diverse backgrounds with research or health professional doctorates in medicine, surgery, nursing, dentistry, public health, psychiatry, arts and sciences, and engineering. The KL2 program will promote career development, translational capabilities, and collaborative and entrepreneurial skills of junior faculty from diverse disciplines who have recently finished research or health professional doctoral training. KL2 graduates will receive excellent and extensive career mentoring, and gain expertise in advanced clinical and translational research methods and comprehensive experimental approaches. This mentoring and training will allow KL2 scholars to compete more effectively for external funding, enhance their effective participation in interdisciplinary teams, and contribute to prevention and treatment of diseases through clinical and translational research. Our KL2 graduates will also be able to pay forward these skills through training and mentorship of the next generation of scientists. As such, the Specific Aims are: Aim 1. To continue our successful and innovative KL2 career development program and develop new programs to enhance the ability of our KL2 scholars to engage in and lead interdisciplinary team science and translate new discoveries to benefit our patients and communities. Aim 2. To demonstrate the effectiveness of the KL2 program through continuous comprehensive and systematic evaluation and quality improvement using key metrics, including Common Metrics, to optimize the impact of our educational and workforce development programs. Aim 3. To accelerate the dissemination of our training approaches to our partners at Columbia University (CU), the regional tri-state consortium (TriCon) of Clinical and Translational Science Award (CTSA) Program hubs and network, and the clinical and translational while enhancing and innovating our successful junior faculty training field at large.
期刊论文(56)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/apt.13249
发表时间: 2015-07
期刊: Alimentary pharmacology & therapeutics
影响因子: 7.6
作者: [Lebwohl B, Green PH, Genta RM]
通讯作者: Genta RM
In Reply: Spontaneous MAOI hypertensive reaction, not likely armodafinil - tranylcypromine interaction.
答复:自发性 MAOI 高血压反应,不太可能是阿莫达非尼 - 反苯环丙明相互作用。
DOI: 10.1016/j.jns.2019.01.002
发表时间: 2019
期刊: Journal of the neurological sciences
影响因子: 4.4
作者: [Kinslow,ConnorJ, Miller,ElizaC]
通讯作者: Miller,ElizaC
Long-term outcomes of mesial temporal laser interstitial thermal therapy for drug-resistant epilepsy and subsequent surgery for seizure recurrence: a multi-centre cohort study.
颞内侧激光间质热疗治疗耐药性癫痫和随后手术治疗癫痫复发的长期结果:一项多中心队列研究。
DOI: 10.1136/jnnp-2022-330979
发表时间: 2023
期刊: Journal of neurology, neurosurgery, and psychiatry
影响因子: --
作者: [Youngerman,BrettE, Banu,MateiA, Khan,Farhan, McKhann,GuyM, Schevon,CatherineA, Jagid,JonathanR, Cajigas,Iahn, Theodotou,ChristianB, Ko,Andrew, Buckley,Robert, Ojemann,JeffreyG, Miller,JohnW, Laxton,AdrianW, Couture,DanielE, Popli,]
通讯作者: Popli,
Comparing survival of older ovarian cancer patients treated with neoadjuvant chemotherapy versus primary cytoreductive surgery: Reducing bias through machine learning.
比较接受新辅助化疗与初次细胞减灭术治疗的老年卵巢癌患者的生存率:通过机器学习减少偏差。
DOI: 10.1016/j.ygyno.2024.03.016
发表时间: 2024
期刊: Gynecologic oncology
影响因子: 4.7
作者: [Huang,Yongmei, Rauh-Hain,JAlejandro, McCoy,ThomasH, Hou,JuneY, Hillyer,Grace, Ferris,JenniferS, Hershman,Dawn, Wright,JasonD, Melamed,Alexander]
通讯作者: Melamed,Alexander
33
    Coordinating Center for the Program on the Origins of Gastroesophageal Cancers
    Coordinating Center for the Program on the Origins of Gastroesophageal Cancers
    Institutional Career Development Core
    Early Detection of Ovarian Cancer Through Epigenetic Factors in the WHI
    国内基金
    海外基金
    企业绩效评价的DEA-Benchmarking方法及动态博弈研究
    • 批准号:
      70571028
    • 项目类别:
      面上项目
    • 资助金额:
      16.5万元
    • 批准年份:
      2005
    • 负责人:
      杨印生
    • 依托单位: